Download Full Text (539 KB)


  • Algorithm for Treating Advanced Ovarian Cancer Increases Complete Resection Rate: Most ovarian cancers have spread beyond the ovary by the time they are diagnosed, and they often recur even after responding to primary treatment. Researchers at The University of Texas MD Anderson Cancer Center aim to improve patient outcomes by changing the standard approach to newly diagnosed advanced ovarian cancer.
  • Clinical Trials Explore Systemic Treatments for Brain Metastases from Breast Cancer: Brain metastases from breast cancer are difficult to treat because many of the systemic drugs that are effective against breast cancer cannot cross the blood-brain barrier. But researchers at The University of Texas MD Anderson Cancer Center are working to overcome this challenge and are testing new systemic treatments for breast cancer brain metastases in three clinical trials.
  • HOUSE CALL: Tips for Communicating with Health Care Providers-Preparing for appointments can help you get the answers you need
  • INBRIEF: Sentinel Lymph Node Mapping Identifies Node-Positive, High-Risk Endometrial Cancer

Publication Date



The University of Texas MD Anderson Cancer Center


Houston, Texas


Nick, Alpa; Westin, Shannon; Fagotti, Anna; Sood, Anil, M.D.; Ibrahim, Nuhad; Soliman, Pamela; Ovarian Neoplasms; Antineoplastic Agents; Genetic Testing; Genes, BRCA1; Genes, BRCA2; Mutation; Surgical Procedures, Operative; Radiotherapy; Clinical Trials as Topic; Breast Neoplasms; Brain Neoplasms -- secondary; Quinolines; Peptides; Patients; Endometrial Neoplasms; Sentinel Lymph Node.


History of Science, Technology, and Medicine | Oncology

Conditions Governing Access


OncoLog, Volume 60, Number 05, May 2015